Drugs / Interferon alfa-n1
Interferon alfa-n1
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00001113 | ? → Mar 1990 | HIV infectious disease, Kaposi's sarcoma | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 1 | NCT00000725 | ? → Feb 1990 | HIV infectious disease, Kaposi's sarcoma | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00002086 | — | HIV infectious disease | Glaxo Wellcome | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT00000844 | ? → Jun 2002 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| — | NCT00000647 | ? → Dec 1994 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon alfa-n1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000647 ↗ |
| Known as | IFN-A | “interferon-alfa (IFN-A)” NCT00000647 ↗ |
| Known as | interferon-alfa | “interferon-alfa (IFN-A)” NCT00000647 ↗ |
| Known as | Wellferon | “Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 )” NCT00002086 ↗ |
| Modality | Protein / enzyme biologic | “Human Interferon Alpha” NCT00000725 ↗ |
| Route | Oral | “low-dose oral alpha-interferon (alpha-IFN)” PMID 10634196 ↗ Dec 1999 |